Cargando…

Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study

INTRODUCTION: Elevated serum levels of S100β, an astrocyte-derived protein, correlate with unfavourable neurological outcomes following cardiac surgery, neurotrauma, and resuscitation. This study evaluated whether pre-/postoperative serum S100β levels correlate with unfavourable clinical and radiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Einav, Sharon, Shoshan, Yigal, Ovadia, Haim, Matot, Idit, Hersch, Moshe, Itshayek, Eyal
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751042/
https://www.ncbi.nlm.nih.gov/pubmed/17020600
http://dx.doi.org/10.1186/cc5058
_version_ 1782131411441942528
author Einav, Sharon
Shoshan, Yigal
Ovadia, Haim
Matot, Idit
Hersch, Moshe
Itshayek, Eyal
author_facet Einav, Sharon
Shoshan, Yigal
Ovadia, Haim
Matot, Idit
Hersch, Moshe
Itshayek, Eyal
author_sort Einav, Sharon
collection PubMed
description INTRODUCTION: Elevated serum levels of S100β, an astrocyte-derived protein, correlate with unfavourable neurological outcomes following cardiac surgery, neurotrauma, and resuscitation. This study evaluated whether pre-/postoperative serum S100β levels correlate with unfavourable clinical and radiological findings in patients undergoing elective meningioma resection. METHODS: In 52 consecutive patients admitted for meningioma surgery, serum S100β levels were determined upon admission and immediately, 24 hours, and 48 hours after surgery. All patients underwent complete pre- and postoperative neurological examination and mini-mental state examination. Radiological evaluation included preoperative magnetic resonance imaging (MRI) and postoperative computed tomography. Tumour volume, brain edema, and bleeding volume were calculated using BrainSCAN™ software. RESULTS: Preoperative S100β levels did not correlate with the tumour characteristics demonstrated by preoperative MRI (for example, tumour volume, edema volume, ventricular asymmetry, and/or midline shift). Preoperative serum S100β levels (0.065 ± 0.040 μg/l) were significantly lower than the levels measured immediately (0.138 ± 0.081 μg/l), 24 hours (0.142 ± 0.084 μg/l), and 48 hours (0.155 ± 0.119 μg/l) postoperatively (p < 0.0001). Significantly greater postcraniotomy S100β levels were observed with prolonged surgery (p = 0.039), deterioration in the mini-mental state examination (p = 0.005, 0.011, and 0.036 for pre versus immediate, 24 hours, and 48 hours postsurgery, respectively), and with postoperative brain computed tomography evidence of brain injury; bleeding was associated with higher serum S100β levels at 24 and 48 hours after surgery (p = 0.046, 95% confidence interval [CI] -0.095 to -0.001 and p = 0.034, 95% CI -0.142 to -0.006, respectively) as was the presence of midline shift (p = 0.005, 95% CI -0.136 to -0.025 and p = 0.006, 95% CI -0.186 to -0.032, respectively). Edema was associated with higher serum S100β levels immediately (p = 0.022, 95% CI -0.092 to -0.007) and at 48 hours after surgery (p = 0.017, 95% CI -0.142 to -0.026). The degree of elevation in S100β levels at 24 and 48 hours after surgery also correlated with the severity of midline shift and edema. CONCLUSION: In patients with meningioma, serum S100β levels perform poorly as an indicator of tumour characteristics but may suggest ongoing postcraniotomy injury. Serum S100β levels may serve as a potentially useful early marker of postcraniotomy brain damage in patients undergoing elective meningioma resection.
format Text
id pubmed-1751042
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17510422006-12-27 Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study Einav, Sharon Shoshan, Yigal Ovadia, Haim Matot, Idit Hersch, Moshe Itshayek, Eyal Crit Care Research INTRODUCTION: Elevated serum levels of S100β, an astrocyte-derived protein, correlate with unfavourable neurological outcomes following cardiac surgery, neurotrauma, and resuscitation. This study evaluated whether pre-/postoperative serum S100β levels correlate with unfavourable clinical and radiological findings in patients undergoing elective meningioma resection. METHODS: In 52 consecutive patients admitted for meningioma surgery, serum S100β levels were determined upon admission and immediately, 24 hours, and 48 hours after surgery. All patients underwent complete pre- and postoperative neurological examination and mini-mental state examination. Radiological evaluation included preoperative magnetic resonance imaging (MRI) and postoperative computed tomography. Tumour volume, brain edema, and bleeding volume were calculated using BrainSCAN™ software. RESULTS: Preoperative S100β levels did not correlate with the tumour characteristics demonstrated by preoperative MRI (for example, tumour volume, edema volume, ventricular asymmetry, and/or midline shift). Preoperative serum S100β levels (0.065 ± 0.040 μg/l) were significantly lower than the levels measured immediately (0.138 ± 0.081 μg/l), 24 hours (0.142 ± 0.084 μg/l), and 48 hours (0.155 ± 0.119 μg/l) postoperatively (p < 0.0001). Significantly greater postcraniotomy S100β levels were observed with prolonged surgery (p = 0.039), deterioration in the mini-mental state examination (p = 0.005, 0.011, and 0.036 for pre versus immediate, 24 hours, and 48 hours postsurgery, respectively), and with postoperative brain computed tomography evidence of brain injury; bleeding was associated with higher serum S100β levels at 24 and 48 hours after surgery (p = 0.046, 95% confidence interval [CI] -0.095 to -0.001 and p = 0.034, 95% CI -0.142 to -0.006, respectively) as was the presence of midline shift (p = 0.005, 95% CI -0.136 to -0.025 and p = 0.006, 95% CI -0.186 to -0.032, respectively). Edema was associated with higher serum S100β levels immediately (p = 0.022, 95% CI -0.092 to -0.007) and at 48 hours after surgery (p = 0.017, 95% CI -0.142 to -0.026). The degree of elevation in S100β levels at 24 and 48 hours after surgery also correlated with the severity of midline shift and edema. CONCLUSION: In patients with meningioma, serum S100β levels perform poorly as an indicator of tumour characteristics but may suggest ongoing postcraniotomy injury. Serum S100β levels may serve as a potentially useful early marker of postcraniotomy brain damage in patients undergoing elective meningioma resection. BioMed Central 2006 2006-10-04 /pmc/articles/PMC1751042/ /pubmed/17020600 http://dx.doi.org/10.1186/cc5058 Text en Copyright © 2006 Einav et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Einav, Sharon
Shoshan, Yigal
Ovadia, Haim
Matot, Idit
Hersch, Moshe
Itshayek, Eyal
Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
title Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
title_full Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
title_fullStr Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
title_full_unstemmed Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
title_short Early postoperative serum S100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
title_sort early postoperative serum s100β levels predict ongoing brain damage after meningioma surgery: a prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751042/
https://www.ncbi.nlm.nih.gov/pubmed/17020600
http://dx.doi.org/10.1186/cc5058
work_keys_str_mv AT einavsharon earlypostoperativeserums100blevelspredictongoingbraindamageaftermeningiomasurgeryaprospectiveobservationalstudy
AT shoshanyigal earlypostoperativeserums100blevelspredictongoingbraindamageaftermeningiomasurgeryaprospectiveobservationalstudy
AT ovadiahaim earlypostoperativeserums100blevelspredictongoingbraindamageaftermeningiomasurgeryaprospectiveobservationalstudy
AT matotidit earlypostoperativeserums100blevelspredictongoingbraindamageaftermeningiomasurgeryaprospectiveobservationalstudy
AT herschmoshe earlypostoperativeserums100blevelspredictongoingbraindamageaftermeningiomasurgeryaprospectiveobservationalstudy
AT itshayekeyal earlypostoperativeserums100blevelspredictongoingbraindamageaftermeningiomasurgeryaprospectiveobservationalstudy